MedTrace Logo

Expression Profile Study of Macrophages From Patients Affected by ALS or Other Related Motor Impairments

NCT04816227 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 180

Last updated 2026-03-09

No results posted yet for this study

Summary

The aim of this project is to analyze the macrophage transcriptome and protein markers of Amyotrophic Lateral Sclerosis (ALS) patients compared to controls (non-affected individuals, patients with other motor impairments) and asymptomatic ALS gene carriers, to find new pathways for therapeutic targets and disease biomarkers.

Conditions

Sponsors & Collaborators

  • Institut National de la Santé Et de la Recherche Médicale, France

    lead OTHER_GOV

Principal Investigators

  • François SALACHAS, MD · APHP, Hôpital de la Salpêtrière, INSERM U1127, ICM

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-09-29
Primary Completion
2027-09-30
Completion
2027-09-30

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04816227 on ClinicalTrials.gov